GI & Endoscopy

Here are three gastroenterologists in the news this past week.

Allergan is in the midst of acquiring Motus Therapeutics, a subsidiary of Rhythm Holding Company, after its relamorelin prescription achieved top line results in a phase 2b clinical trial.

A study in Cancer Epidemiology Biomakers & Prevention found that regularly consuming coffee decreases risk of colorectal cancer, Hometown Focus reports.

A study in Hepatology found that the prevalence of nonalcoholic fatty liver disease in the United States leads to direct medical costs of more than $100 billion each year.

The American Gastroenterological Association has expanded its Patient INFO Center with a resource guide on inflammatory bowel disease and pregnancy.

R. David Shepard, MD, is a gastroenterologist with Tampa, Fla.-based Florida Medical Clinic.

Waqqas Afif, MD, will be honored by the McGill IBD Research Group at its first fundraising event, The Suburban reports.

Boston Scientific exceeded projections for its third quarter after posting stronger than expected revenues, the Wall Street Journal reports.

Lack of communication may lead to the underdiagnosis of chronic gastrointestinal conditions, according to a survey of gastroenterologists, primary care physicians and adult patients with GI issues.

Here are three updates on gastroenterology and endoscopy companies.